⚙️
🌟 Najlepsze dopasowanie
Wpisz szukaną frazę, aby zobaczyć propozycje AI.

Vaccine safe at every step

Photo: Pixabay

The world is facing a huge challenge related to the safe distribution and administration of the COVID-19 vaccine to as large a part of the global population as possible in the shortest possible time. WHO and Deloitte recommend GS1 standards to streamline the supply chain and guarantee vaccine safety.

The coronavirus pandemic has contributed to the finalization of over 30 years of work on the mRNA vaccine. However, the demand for vaccines is not the only challenge that manufacturers and governments of individual countries are facing. Managing the production and flow of vaccines requires careful supply chain planning with a special emphasis on patient safety, and earlier, the safety of the vaccines themselves on their long journey from the manufacturer to the place of administration. It would be helpful to use GS1 standards proven in other industries.

Vaccines at controlled temperatures
Transporting and storing COVID-19 vaccines requires specific temperature conditions. For example, the Pfizer vaccine, produced in two locations worldwide, requires storage in special containers at -70°C and transport in dry ice at -80°C. After thawing, it must be stored at a temperature between +2°C and +8°C and used within 5 days. In turn, the Moderna vaccine requires -20°C during storage, and after thawing, it can be stored for thirty days at a temperature between +2°C and +8°C. AstraZeneca has created a vaccine that does not require deep freezing, which makes it easier to create several regional supply chains based on 20 suppliers from 50 countries.

– All coronavirus vaccines require the use of cold chain technology in transport and storage, similar to drugs used in the treatment of cancer or immune disorders. Ensuring the effectiveness of the preparations involves recording and collecting data about them at every stage of the supply chain – says Sławomir Błotny, advisor to the Management Board of Arra Group, a Polish logistics company participating in the European distribution of COVID vaccines. This is where GS1 solutions for traceability work well, e.g., the Global Traceability Standard (GS1 GTS). Thanks to it, you can track the vaccine backwards to identify the history of its movement and location. You can also track it forward to see the intended path of the product to the vaccination point.

No vial will be wasted
Another major logistical challenge is organizing work in the final phase of the supply chain, i.e., at vaccination points. Both the Pfizer and Moderna vaccines were designed to be administered in a series of two doses – the Pfizer vaccine at an interval of three weeks, and the Moderna vaccine at an interval of four weeks. Therefore, it is necessary to ensure efficient flow of information between the point and the patient and take into account the risk of the patient not showing up at the scheduled time.

– Currently, over 70 countries use two-dimensional GS1 DataMatrix barcodes. They allow responsible entities to enter a series of important information identifying drugs in the form of a two-dimensional code, and thus reduce the risk of errors. Thanks to scanning GS1 DataMatrix codes and with the support of appropriate ICT infrastructure, it is also possible to effectively and efficiently plan the vaccination process, avoiding the need to dispose of unused vaccine doses – comments Dr. Anna Gawrońska, expert on GS1 standards in healthcare, Łukasiewicz-ILiM.

Original vaccine only with a code
COVID-19 vaccines turned out to be a scarce commodity, and it did not take long to wait for the first signals of successful attempts to counterfeit them. The World Health Organization (WHO) strongly recommends introducing mechanisms that will allow for the unambiguous identification of vaccines using appropriate data on the label along with a graphic representation of this data. In turn, the publication on the distribution of coronavirus vaccines prepared by Deloitte clearly justifies the need to standardize the way vaccines are identified globally using GS1 barcodes. The GS1 DataMatrix barcode allows for the graphic representation of the 13-digit Global Trade Item Number (GTIN) along with additional data, i.e., batch number and expiration date. Barcodes compliant with GS1 standards uniquely identify medical products, including vaccines, from the laboratory through clinical trials to the administration stage.
National vaccination campaigns are being conducted under incredible time pressure all over the world, and standards can help reduce the burden on healthcare workers and reduce the risk of errors. The use of GS1 standards reduces the risk of diversion, vaccine expiration, and the distribution of counterfeit copies. Thanks to this, the public can be sure that both the vaccine itself and the process of its introduction to the market are safe.

Source: GS1 Poland

Read more about safe vaccine distribution:
– Deloitte reminds: “Track every dose of the vaccine!”